Skip to main content
. Author manuscript; available in PMC: 2018 Jul 2.
Published in final edited form as: N Engl J Med. 2012 Mar 15;366(11):981–990. doi: 10.1056/NEJMoa1113135

Figure 1. Flow diagram of the ERSPC trial.

Figure 1

* Low risk= T1,T2 with Gleason score (GS) <= 6; Intermediate risk = T1,T2 with GS 7 and T3 with GS <=7; High risk = T1,T2,T3 with GS 8-10 and T4 with any GS; M1 and/or PSA > 100 = any T stage or GS with M1 and/or PSA > 100.

§ More detailed data on prognostic factors are provided in tables 5A, 5B and 5C of the supplementary appendix